Osteoarthritis in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis

被引:0
|
作者
Giannopapas, Vasileios [1 ,2 ]
Smyrni, Vassiliki [1 ]
Kitsos, Dimitrios K. [1 ]
Stasi, Sophia [3 ]
Chasiotis, Athanasios K. [1 ,2 ]
Moschovos, Christos [1 ]
Papagiannopoulou, Georgia [1 ]
Stavrogianni, Konstantina [1 ,4 ]
Kosmidou, Maria [5 ]
Bakalidou, Daphne [1 ]
Tzartos, John S. [1 ]
Tsivgoulis, Georgios [1 ]
Giannopoulos, Sotirios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Neurol 2, Athens 11528, Greece
[2] Univ West Attica, Dept Phys Therapy, Egaleo 12243, Greece
[3] Univ Peloponnese, Dept Phys Therapy, Sparti 23100, Greece
[4] Univ Ioannina, Fac Med, Dept Physiol, 45110 Ioannina, Greece
[5] Univ Ioannina, Fac Med, Dept Internal Med, Ioannina 45110, Greece
关键词
multiple sclerosis; arthritis; osteoarthritis; autoimmune diseases; NATIONAL BURDEN; GLOBAL BURDEN; DISEASE; EPIDEMIOLOGY; STROKE;
D O I
10.3390/jcm13175015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Arthritis, particularly osteoarthritis (OA), is a common synovial condition observed in individuals with multiple sclerosis (MS). Despite its high prevalence and significant impact on the quality of life of MS individuals, there is a gap in the current literature regarding the prevalence of OA in this population and its relation to MS pathology. This systematic review and meta-analysis aimed to estimate the prevalence of OA in the MS population and explore potential associations with demographic and MS-specific characteristics. Methods: Adhering to PRISMA guidelines, a systematic search of the MEDLINE PubMed, Scopus and Google Scholar databases was conducted. Results: Fifteen studies were included in the systematic review and meta-analysis. The aggregated prevalence of OA in the MS population was 27% (95% CI: 15-40%), with substantial heterogeneity (I2 = 99.9%). Sensitivity analysis, excluding one study, showed a prevalence of 21% (95% CI: 16-28%). The risk ratio of OA in MS versus controls was 1.07 (95% CI: 0.84-1.37), indicating no significant difference. Meta-regression revealed no associations between OA prevalence and age or disease duration in MS patients. Conclusions: This study reports a 21-27% prevalence of OA in people with MS. Understanding the implications of OA in pain and mobility domains, as well as the challenges in distinguishing OA symptoms from MS manifestations, underscores the need for further research to elucidate the pathophysiological mechanisms and interactions between these conditions. Additional studies are warranted to enhance clinical management and improve outcomes for individuals with MS and co-existing OA.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Toxoplasma gondii and multiple sclerosis: A systematic review and meta-analysis
    Cicero, Calogero Edoardo
    Allibrio, Francesca Elsa
    Giuliano, Loretta
    Luna, Jaime
    Preux, Pierre-Marie
    Nicoletti, Alessandra
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (12) : 4251 - 4257
  • [32] Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis
    Shen, Meng-Han
    Ng, Chau Yee
    Chang, Kuo-Hsuan
    Chi, Ching-Chi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Attrition Within Digital Health Interventions for People With Multiple Sclerosis: Systematic Review and Meta-analysis
    Bevens, William
    Weiland, Tracey
    Gray, Kathleen
    Jelinek, George
    Neate, Sandra
    Simpson-Yap, Steve
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (02)
  • [34] Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis
    Daniel Hind
    Jack Cotter
    Anna Thake
    Mike Bradburn
    Cindy Cooper
    Claire Isaac
    Allan House
    BMC Psychiatry, 14
  • [35] The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Phyo, Aung Zaw Zaw
    Demaneuf, Thibaut
    De Livera, Alysha M.
    Jelinek, George A.
    Brown, Chelsea R.
    Marck, Claudia H.
    Neate, Sandra L.
    Taylor, Keryn L.
    Mills, Taylor
    O'Kearney, Emily
    Karahalios, Amalia
    Weiland, Tracey J.
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [36] Immunizations and risk of multiple sclerosis: systematic review and meta-analysis
    Farez, Mauricio F.
    Correale, Jorge
    JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1197 - 1206
  • [37] Immunizations and risk of multiple sclerosis: systematic review and meta-analysis
    Mauricio F. Farez
    Jorge Correale
    Journal of Neurology, 2011, 258 : 1197 - 1206
  • [38] Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis
    Xiao-Li Guan
    Hui Wang
    Hai-Shan Huang
    Ling Meng
    Neurological Sciences, 2015, 36 : 671 - 681
  • [39] Misdiagnosis and underdiagnosis of multiple sclerosis: A systematic review and meta-analysis
    Zuerrer, Wolfgang Emanuel
    Cannon, Amelia Elaine
    Ilchenko, Dariya
    Gaitan, Maria Ines
    Granberg, Tobias
    Piehl, Fredrik
    Solomon, Andrew J.
    Ineichen, Benjamin Victor
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (11-12) : 1409 - 1422
  • [40] Vascular function in multiple sclerosis: Systematic review with meta-analysis
    Zheng, Peixuan
    DuBose, Noah G.
    DeJonge, Sydney R.
    Jeng, Brenda
    Hibner, Brooks A.
    Motl, Robert W.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91